The company's business scope mainly includes the production and sales of ephedrine and other raw materials, small water injections, tablets, capsules, granules, bulk; pharmaceutical new products, new technology development, introduction, transfer, consultation, service and training. The main products are Ephedrine Hydrochloride, Pseudoephedrine Hydrochloride, Racemic Mephedrine Hydrochloride, Methylpseudoephedrine Hydrochloride, Pseudoephedrine Sulfate, Norepseudoephedrine Hydrochloride and its series of products, and Erythromycin, Ephedrazolone, Balsalazide and other chemical synthesis products.
The company has inherited the production technology of Chifeng Pharmaceutical Factory for more than 50 years for the production of ephedrine by chemical extraction method of Ephedra, which has a perfect, advanced and stable technological process. Its chemical extraction products have been recorded in the history as the first pharmaceutical chemical raw materials of *** and the country to go to the international market, and ephedrine hydrochloride and pseudoephedrine hydrochloride have both won the national quality gold medal. 2001 put into production the chemical synthesis method of ephedrine production project is in line with the national industrial policy, and owns the independent intellectual property rights, it is the world's pioneer in the synthesis of ephedrine by the whole chemical method, with the international leading level. The implementation of this project makes our company become the only one enterprise in China that produces ephedrine on a large scale by all-chemical method. With the increasing awareness of environmental protection and the gradual expansion of the scale of all-chemical production of ephedrine, the all-chemical synthesis of ephedrine will gradually replace the production of chemically extracted ephedrine from Ephedra, and its ecological and economic benefits will also be fully realized. All-chemical production of ephedrine with its advanced technology, high-quality products, competitive costs to participate in the domestic and international market competition, and promote the development of ephedrine industry in China. The project of chemical production of synthetic ephedrine, as the first technology in China, has been successively included in the double-high and one-excellent project of the State Economic and Trade Commission, the Torch Plan project of the Ministry of Science and Technology of the People's Republic of China as well as the seventh period of the national bond subsidized interest project.
For the development of the enterprise, the company has done a lot of work in the export of products, the company was the first one in the industry to pass the on-site inspection of the U.S. Food and Drug Administration (FDA) in 2002, and passed the certification of European Pharmacopoeia applicability at the end of the same year (referred to as the COS certificate), and the company is the only one in the country to have passed the inspection of the FDA and the certification of the COS at the same time. As a result, we have opened a green channel to enter the international market of Europe and the United States, and gradually established long-term cooperative relationships with many famous international companies, and the export volume of our products has been increasing year by year. We have passed the quality audits of GlaxoSmithKline (UK), CMS, Wyeth Bengal Pharmaceuticals, Paragon Pharmaceuticals, Shanghai Squibb, Shanghai Johnson & Johnson Pharmaceuticals for three consecutive years and won the best supplier of CMS Tianjin Pharmaceuticals for three consecutive years, and was awarded the best partner and excellent supplier of Shanghai Johnson & Johnson Pharmaceuticals for 2005 and again for 2007, and was awarded the best partner and excellent supplier of Shanghai Johnson & Johnson Pharmaceuticals for 2007. In 2005, we were honored as the best partner and excellent supplier of Shanghai Johnson & Johnson Pharmaceutical Company, and in 2007, we were honored as the excellent supplier of Shanghai Johnson & Johnson Pharmaceutical Company. Through the annual supplier audit of the above company, our company has been able to improve the quality of products and services, operating procedures and rules and regulations, and has won a high business reputation in the international and domestic industry, which has laid a solid foundation for the subsequent development of the company.